| [1] |
Daqing DENG,Juan ZHOU,Jia WANG,Yiqun LIU,Keqin CHEN,Lin ZHOU,Xiehong LIU.
Expression changes of heat shock protein B-1 in myocardial injury and its regulatory effect on the maturation process of TGF-β1
[J]. The Journal of Practical Medicine, 2026, 42(14): 2477-2487.
|
| [2] |
Yue LV,Yanna MENG,Panpan LI,Yinghong. CHEN.
Value of SWD in preoperative assessment of liver fibrosis in patients with hepatocellular carcinoma
[J]. The Journal of Practical Medicine, 2025, 41(5): 751-755.
|
| [3] |
Tianzhong PENG,Xuedi HUANG,Xingzhen LIN,Juan YUAN,Feng ZHOU,Langhui LIU,Qi′nan ZHAN,Manhua. ZHU.
Effect of Kaiqiao Xingshen acupuncture combined with Buyang Huanwu decoction on IL⁃2, MMP⁃9, BDNF, and cerebral blood flow in patients with cerebral hemorrhage during recovery period (Qi deficiency and blood stasis syndrome)
[J]. The Journal of Practical Medicine, 2025, 41(3): 428-433.
|
| [4] |
Yebao WANG,Yongping LIN,Ling LIU,Jianmin. LI.
Correlation of serum miR‑210, TSG‑6 and CTRP3 with myocardial fibrosis and prognosis in patients with dilated cardiomyopathy
[J]. The Journal of Practical Medicine, 2025, 41(23): 3690-3696.
|
| [5] |
Shuo LI,Yunpeng ZHANG,Yan HUANG,Jing WANG,yang BAI,Shuzhong. DUAN.
The relationship between remnant cholesterol and clinicopathological characteristics in patients with IgA nephropathy
[J]. The Journal of Practical Medicine, 2025, 41(21): 3322-3329.
|
| [6] |
Xueying MA,Xiangming MA.
Research progress on serum⁃based assessment methods for liver fibrosis in patients with non⁃alcoholic fatty liver disease
[J]. The Journal of Practical Medicine, 2025, 41(15): 2290-2303.
|
| [7] |
Xiaoyue LI,Na WANG,Xianni LIU,Tingli DAI,Haiwen CHEN,Jianguo XIN,Wei WANG,Menglan ZHANG.
Analysis of the relationship between stromal fibrosis degree and targeted therapy resistance and prognosis in EGFR mutant lung adenocarcinoma
[J]. The Journal of Practical Medicine, 2025, 41(15): 2381-2387.
|
| [8] |
Jingyao LI,Xiaodi ZHU,Fei SU,Yunfeng ZHANG,Nilin ZHANG,Qiquan LIU.
Association of Hp infection with inflammatory factors and hepatic fibrosis progression in metabolically associated fatty liver disease with type 2 diabetes mellitus
[J]. The Journal of Practical Medicine, 2025, 41(13): 2045-2051.
|
| [9] |
Ting DENG,Qiang FU,Zhiliang LI,Qingmin CHU,Xiaoxiong. ZHOU.
Study on the improvement of cardiac and renal function in rats with cardiorenal syndrome by inhibiting fibrosis with 6-gingerol
[J]. The Journal of Practical Medicine, 2025, 41(11): 1627-1636.
|
| [10] |
Xin ZHAO,Hui LI,Xiuxiu DENG,Yujing. TAO.
Antiplatelet drugs and liver fibrosis
[J]. The Journal of Practical Medicine, 2024, 40(8): 1083-1087.
|
| [11] |
Renling YAO,Yixuan ZHU,Rui HUANG,Jie LI.
The association between vitamin intake and the progression of metabolic dysfunction⁃associated fatty liver disease
[J]. The Journal of Practical Medicine, 2024, 40(6): 820-826.
|
| [12] |
Juan TANG,Yi LI,Liqiong ZHAI,Shaowen LIU,Yong SHEN,Shuo CONG,Yongmei. LIU.
The diagnostic value of miR⁃571 levels in blood from the peripherals in liver fibrosis
[J]. The Journal of Practical Medicine, 2024, 40(5): 653-657.
|
| [13] |
Ningjing SONG,Jing ZHOU,Biwei CAO,Yan ZHAO,Yunyang YU,Hanli LEI,Yujun. LUO.
TGF⁃β′s role in skeletal muscle injury repair: Mechanism and research advances
[J]. The Journal of Practical Medicine, 2024, 40(5): 721-726.
|
| [14] |
Aiqin LI,Zhen ZHANG,Ya′nan XU,Jinyuan ZHU,Xu. ZHANG.
Research progress on the interaction between macro⁃phages and fibroblasts in ARDS pulmonary fibrosis
[J]. The Journal of Practical Medicine, 2024, 40(4): 571-574.
|
| [15] |
Yingyuan ZHANG,Chunyan MOU,Danqing XU,Yuanzhen WANG,Lixian CHANG,Chunyun LIU,Weikun LI,Hongyan WEI,Li LIU.
Comparison of clinical efficacy of TMF and TDF in the treatment of hepatitis B liver fibrosis
[J]. The Journal of Practical Medicine, 2024, 40(22): 3215-3220.
|